David P. Schenkein

2014

In 2014, David P. Schenkein earned a total compensation of $4.4M as President and Chief Executive Officer at Agios Pharmaceuticals, a 174% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$371,250
Option Awards$3,486,013
Salary$500,000
Other$1,978
Total$4,359,241

Schenkein received $3.5M in option awards, accounting for 80% of the total pay in 2014.

Schenkein also received $371.3K in non-equity incentive plan, $500K in salary and $2K in other compensation.

Rankings

In 2014, David P. Schenkein's compensation ranked 1,907th out of 13,032 executives tracked by ExecPay. In other words, Schenkein earned more than 85.4% of executives.

ClassificationRankingPercentile
All
1,907
out of 13,032
85th
Division
Manufacturing
671
out of 4,967
87th
Major group
Chemicals And Allied Products
212
out of 1,690
88th
Industry group
Drugs
163
out of 1,369
88th
Industry
Pharmaceutical Preparations
136
out of 1,042
87th
Source: SEC filing on April 24, 2017.

Schenkein's colleagues

We found four more compensation records of executives who worked with David P. Schenkein at Agios Pharmaceuticals in 2014.

2014

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2014

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2014

J Higgons

Agios Pharmaceuticals

Chief Operating Officer

2014

Glenn Goddard

Agios Pharmaceuticals

Former Sr. Vice President, Finance

News

In-depth

You may also like